Source: Program. Conference titles: Brazilian Congress of Pharmacology and Experimental Therapeutics. Unidade: FCFRP
Subjects: ANTIPIRÉTICOS (EFEITOS), SISTEMA NERVOSO CENTRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALVAR, D. C. et al. Antipyretic effect and central nervous system amount of dipyrone active metabolites, 4-methylaminoantipyrine (4-MAA) and 4-aminoantipyrine (4-AA). 2012, Anais.. Foz do Iguaçu: SBFTE, 2012. . Acesso em: 21 maio 2024.APA
Malvar, D. C., Aguiar, F. A., Vaz, A., Assis, D. C. R., Melo, M. C. C., Clososki, G. C., et al. (2012). Antipyretic effect and central nervous system amount of dipyrone active metabolites, 4-methylaminoantipyrine (4-MAA) and 4-aminoantipyrine (4-AA). In Program. Foz do Iguaçu: SBFTE.NLM
Malvar DC, Aguiar FA, Vaz A, Assis DCR, Melo MCC, Clososki GC, Jabor VAP, Souza GEP de. Antipyretic effect and central nervous system amount of dipyrone active metabolites, 4-methylaminoantipyrine (4-MAA) and 4-aminoantipyrine (4-AA). Program. 2012 ;[citado 2024 maio 21 ]Vancouver
Malvar DC, Aguiar FA, Vaz A, Assis DCR, Melo MCC, Clososki GC, Jabor VAP, Souza GEP de. Antipyretic effect and central nervous system amount of dipyrone active metabolites, 4-methylaminoantipyrine (4-MAA) and 4-aminoantipyrine (4-AA). Program. 2012 ;[citado 2024 maio 21 ]